Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
Science
Penny Warren

Tom Meade obituary

Tom Meade
Tom Meade directed a thrombosis prevention trial in 1983 that showed taking a combination of aspirin and warfarin could reduce heart attacks Photograph: None

Tom Meade, who has died aged 86, pioneered the field of cardiovascular epidemiology. His research, spanning five decades, gave medical science a vastly improved understanding of the biology of blood and the circulatory system, opening the door for targeted new heart disease treatments.

By the early 1960s, heart disease was the leading cause of death in many countries, with the culprit widely believed to be atheroma (fatty deposits inside the arteries), brought on by high cholesterol and a fatty diet. But in 1965, Meade, a researcher at the Medical Research Council (MRC), read something he described as “a real eye-opener”. His boss, the pre-eminent epidemiologist Jerry Morris, wrote that while the numbers of men dying aged 50-69 had surged since 1908, analysis of autopsy reports showed that the numbers dying with coronary atheroma had decreased. Meade wondered if other factors were in play, and what role blood might have in heart disease. He wanted to investigate.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.